|
|
 |
SODIUM PROPIONATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM CARBONATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AKLIEF Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM STARCH GLYCOLATE TYPE A Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|